Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Reviva Pharmaceuticals's total debt was $44.39K at Sep 30, 2026. For fiscal 2025 it was $406.88K, down 11.2% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $406.88K | -11.2% |
| FY2024 | Dec 31, 2024 | $458.15K | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $44.39K | – |
| Q2 FY2026 | Jun 30, 2026 | $144.09K | +27.2% |
| Q1 FY2026 | Mar 31, 2026 | $231.27K | +3.1% |
| Q4 FY2025 | Dec 31, 2025 | $406.88K | -11.2% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $113.25K | -45.4% |
| Q1 FY2025 | Mar 31, 2025 | $224.30K | -32.4% |
| Q4 FY2024 | Dec 31, 2024 | $458.15K | – |
| Q3 FY2024 | Sep 30, 2024 | $83.00K | -62.7% |
| Q2 FY2024 | Jun 30, 2024 | $207.50K | -6.7% |
| Q1 FY2024 | Mar 31, 2024 | $332.00K | -50.3% |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $222.50K | – |
| Q2 FY2023 | Jun 30, 2023 | $222.50K | – |
| Q1 FY2023 | Mar 31, 2023 | $667.50K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
See a number that looks wrong?